As of 2024-12-13, the Relative Valuation of Celadon Pharmaceuticals PLC (CEL.L) is - GBP. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 GBP, the upside of Celadon Pharmaceuticals PLC based on Relative Valuation is -.
The range of the Relative Valuation is - GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-29 | -1.50 |
| 2024-11-28 | -1.50 |
| 2024-11-27 | -1.50 |
| 2024-11-26 | -1.50 |
| 2024-11-25 | -1.64 |
| 2024-11-22 | -1.50 |
| 2024-11-21 | -1.64 |
| 2024-11-20 | -1.85 |
| 2024-11-19 | -2.20 |
| 2024-11-18 | -2.37 |
| 2024-11-15 | -3.35 |
| 2024-11-14 | -3.29 |
| 2024-11-13 | -3.17 |
| 2024-11-12 | -3.17 |
| 2024-11-11 | -3.17 |
| 2024-11-08 | -3.17 |
| 2024-11-07 | -3.17 |
| 2024-11-06 | -3.35 |
| 2024-11-05 | -3.11 |
| 2024-11-04 | -3.17 |
| 2024-11-01 | -3.29 |
| 2024-10-31 | -3.29 |
| 2024-10-30 | -3.29 |
| 2024-10-29 | -3.41 |
| 2024-10-28 | -3.53 |
| 2024-10-25 | -3.53 |
| 2024-10-24 | -3.47 |
| 2024-10-23 | -3.41 |
| 2024-10-22 | -3.11 |
| 2024-10-21 | -3.11 |
| 2024-10-18 | -3.29 |
| 2024-10-17 | -3.53 |
| 2024-10-16 | -3.65 |
| 2024-10-15 | -3.65 |
| 2024-10-14 | -3.89 |
| 2024-10-11 | -3.89 |
| 2024-10-10 | -3.89 |
| 2024-10-09 | -3.89 |
| 2024-10-08 | -3.89 |
| 2024-10-07 | -3.89 |
| 2024-10-04 | -4.00 |
| 2024-10-03 | -3.77 |
| 2024-10-02 | -3.35 |
| 2024-10-01 | -2.99 |
| 2024-09-30 | -3.29 |
| 2024-09-27 | -4.37 |
| 2024-09-26 | -4.39 |
| 2024-09-25 | -4.25 |
| 2024-09-24 | -4.28 |
| 2024-09-23 | -4.31 |